Wook, WIKI provides more perspective to the patent timing issue under context of generic drug approval dynamics. Both the WIKI write up and FDA URL I provided in my last post contain links providing further information. The FDA links go directly to the Code of Federal Regulations that come into play in responses to questions.
The two links combined with their follow on links ought to help you with answering sceptic questions, but I suggest you satisfy your questions with your own research and encourage others to do their own due diligence.
Why? This is complex stuff and I wouldn't presume I can answer to particulars about pharmaceuticals patent law. That is not my expertise. Perhaps, a lawyer that looks at this board wants to try covering the issue, but I would presume not. Interpretations are scenario specific and there is need for conjecture due to necessary particulars information not being readily available.
Market Data 
Markets 
AI
